Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
6201 SOUTH FREEWAY, FORT WORTH, TX
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
5 Aug 2025

Alcon Inc. merger vote filing

Alcon Inc. filed Form DEFM14A (definitive merger proxy).

23 Apr 2025

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Alcon Inc..

13 Feb 2024

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Alcon Inc..

1 Feb 2024

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Alcon Inc..

23 Feb 2023

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Alcon Inc..

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$2.53B
Total assets (USD)$10.07B
Long-term debt (USD)$0
Debt due within a year (USD)$62.00M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
Verified Financial Statements Unavailable
Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Buy
Target: $83.40
26.1% upside potential
📈
Strong Buy
Unavailable
👍
Buy
7
⏸️
Hold
4
📉
Sell
1
12 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 58.12–102.93 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
Verified Insider Transactions Unavailable
Director and insider transaction data is not ingested for this stock yet.

Top Shareholders

Vanguard Group Inc
21,464,480 shares
1.271% change
12/31/2025
Vanguard Capital Management Llc
14,749,582 shares
-0.821% change
6/30/2026
Bank Of New York Mellon Corp
13,057,962 shares
-16.667% change
6/30/2026
Norges Bank
10,976,697 shares
-8.927% change
6/30/2026
Invesco Ltd.
10,380,332 shares
2786.304% change
6/30/2026
Ako Capital Llp
9,683,004 shares
3.843% change
6/30/2026
Aristotle Capital Management, Llc
9,154,828 shares
-5.82% change
6/30/2026
Zurcher Kantonalbank (Zurich Cantonalbank)
7,915,741 shares
-1.336% change
6/30/2026
Fmr Llc
7,662,988 shares
-38.336% change
6/30/2026
Ubs Group Ag
7,156,307 shares
20.647% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 1 day ago